Nathan Lee Email & Phone Number
@tptherapeutics.com
12 phones found area 310, 858, and 619
LinkedIn matched
Who is Nathan Lee? Overview
A concise factual answer block for searchers comparing this professional profile.
Nathan Lee is listed as Executive Director, Cancer Biology at Riva Therapeutics at Riva Therapeutics, based in Del Mar, California, United States. AeroLeads shows a work email signal at tptherapeutics.com, phone signal with area code 310, 858, 619, and a matched LinkedIn profile for Nathan Lee.
Nathan Lee previously worked as Executive Director, Cancer Biology at Riva Therapeutics and Director, Cancer Biology & Translational Research at Turning Point Therapeutics. Nathan Lee holds Doctor Of Philosophy - Phd, Cell/Cellular And Molecular Biology from Ucla.
Email format at Riva Therapeutics
This section adds company-level context without repeating Nathan Lee's masked contact details.
AeroLeads found 1 current-domain work email signal for Nathan Lee. Compare company email patterns before reaching out.
About Nathan Lee
Oncology Scientist with 10+ years of drug development experience in Cancer Pharmacology. Gained extensive expertise ranging from target validation to translational oncology. Coordinated and supported both IND and NDA filing for multiple drugs, including palbociclib (Ibrance) and bosutinib (Bosulif). Collaborative and resourceful with great interpersonal skills. Seeking to expand skillset and responsibilities in translational medicine, as well as to explore opportunities in the biotech sector.
Listed skills include Drug Discovery, In Vitro, Biomarkers, Oncology, and 13 others.
Nathan Lee's current company
Company context helps verify the profile and gives searchers a useful next step.
Nathan Lee work experience
A career timeline built from the work history available for this profile.
Director, Cancer Biology & Translational Research
Senior Principal Scientist
Principal Scientist
Principal Scientist (Pfizer La Jolla, Oncology) Jul 2013-present-Biology Lead for early discovery cell cycle program to validate target and identify PD response biomarker to support SAR candidate screening and characterization. -Co-Project Leader for follow-on brain-penetrant CDK4/6 inhibitor. -Explore combination therapy to expand Palbociclib (Ibrance) treatment to additional indications beyond HR+ breast cancer. -Developed resistance models to study acquired resistance to Palbociclib (Ibrance). Insights gained from resistance models are guiding development of other follow-on CDK inhibitors to circumvent acquired resistance.Principal Scientist (Pfizer La Jolla, Oncology) Jul 2009-2013-Developed acquired resistance preclinical models for c-MET and EGFR inhibitors to identify resistance mechanisms-Expanded breadth of efficacy and molecular profiling efforts to enable support of an expanded late-stage small molecule portfolio-Coordinated academic collaborations for PI3K and MEK inhibitor programs-Authored non-clinical pharmacology sections of the Palbociclib and Bosutinib NDA submissions
Senior Scientist
Senior Scientist (Pfizer La Jolla, Oncology) Oct 2007 – Jun 2009-Established high through-put 2D and 3D functional cell based assays to screen drugs in single and combination treatments-Collaborated with computational biology group to establish a drug response : molecular profile database to identify response biomarkers for RTK inhibitor compounds such as crizotinib (MET/ALKi) and dacomitinib (EGFRi)-Served as translational pharmacology lead for PI3K/mTOR dual inhibitor and MEK inhibitor programs-Authored non-clinical pharmacology IND filing of PI3K/mTOR dual inhibitorPostdoctoral Fellow (Pfizer La Jolla, Onocology) Oct 2006- Sept 2007-Contributed to small scale translational research efforts to identify unique molecular profiles in cancer cell lines that can help predict sensitivity to RTK small molecule inhibitors and provide insight to combination drug regiments -Performed cell-based proliferation and migration assays to evaluate carcinoma sensitivity to inhibitors of c-MET and EGF receptors
Postdoctoral Researcher
Postdoctoral Fellow (UCLA) Sept 2004 - Sept 2006-Investigated the relationship between two anti-angiogenic molecules and elucidated ADAMTS1 mechanism of action for its anti-angiogenic property -Identified Thrombospondin 1 and 2 as novel substrates for ADAMTS1 and characterized physiological relevance of processing during cutaneous wound healing and angiogenesis using wild type and several knock-out mice models
Nathan Lee education
Doctor Of Philosophy - Phd, Cell/Cellular And Molecular Biology
Bachelor'S Degree, Cell/Cellular And Molecular Biology
Frequently asked questions about Nathan Lee
Quick answers generated from the profile data available on this page.
What company does Nathan Lee work for?
Nathan Lee works for Riva Therapeutics.
What is Nathan Lee's role at Riva Therapeutics?
Nathan Lee is listed as Executive Director, Cancer Biology at Riva Therapeutics at Riva Therapeutics.
What is Nathan Lee's email address?
AeroLeads has found 1 work email signal at @tptherapeutics.com for Nathan Lee at Riva Therapeutics.
What is Nathan Lee's phone number?
AeroLeads has found 12 phone signal(s) with area code 310, 858, 619 for Nathan Lee at Riva Therapeutics.
Where is Nathan Lee based?
Nathan Lee is based in Del Mar, California, United States while working with Riva Therapeutics.
What companies has Nathan Lee worked for?
Nathan Lee has worked for Riva Therapeutics, Turning Point Therapeutics, Pfizer, and University Of California, Los Angeles.
How can I contact Nathan Lee?
You can use AeroLeads to view verified contact signals for Nathan Lee at Riva Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Nathan Lee attend?
Nathan Lee holds Doctor Of Philosophy - Phd, Cell/Cellular And Molecular Biology from Ucla.
What skills is Nathan Lee known for?
Nathan Lee is listed with skills including Drug Discovery, In Vitro, Biomarkers, Oncology, Pharmacology, Assay Development, Molecular Biology, and Target Identification.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial